| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider activity in NTRA over the last quarter tilts toward selling: insiders offloaded a net 267,638 shares worth roughly $62.2M. In the past 30 days, 0 insiders bought and 8 sold. The bias lately has been to the sell side.
Not all activity pointed one way: 8 insiders sold in the same window, though all of them still hold shares. Classified under Life Sciences Tools & Services (Health Care sector), NTRA's insider flows are most useful compared with peers in the same group.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 2.28M | $726.17M | -2,449 | |
| Dir | 245.6K | $78.39M | -5,238 | |
| Pres | 183.8K | $58.65M | -2,008 | |
| Other | 170.1K | $54.28M | -2,221 | |
| Pres | 130.4K | $41.61M | -5,624 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 13, 2024 | Rabinowitz Matthew58 | Executive Chairman | Sell | 160,000 | $165.74 | $26,518,749.54 | -1.3% | -14.4% | +39.3% | |
| Dec 10, 2024 | Chapman Rowan E52 | Director | Sell | 1,767 | $170.24 | $300,808.25 | -22.2% | -20.3% | +40.1% | |
| Dec 9, 2024 | Moshkevich Solomon | President, Clinicaldiagnostics | Sale+OE | 4,858 | $166.59 | $809,312.19 | -4.1% | -21.0% | +40.4% | |
| Dec 2, 2024 | Botha Roelof81 | Director | Sell | 87,473 | $169.12 | $14,793,563.23 | -1.4% | -15.7% | +39.3% | |
| Nov 26, 2024 | Rabinowitz Matthew58 | Executive Chairman | Sell | 4,000 | $166.34 | $665,375.96 | -0.8% | -5.9% | +40.9% | |
| Nov 19, 2024 | Marcus Gail Boxer | Director | Sell | 9,682 | $159.98 | $1,548,930.73 | -31.0% | +4.5% | +34.7% | |
| Nov 15, 2024 | Baynes Roy D. | Director | Sale+OE | 37,230 | $146.11 | $5,439,564.61 | -18.7% | +16.9% | +39.9% | |
| Nov 15, 2024 | Chapman Steven Leonard56 | CEO And President | Sell | 4,728 | $146.41 | $692,209.34 | -0.4% | +16.9% | +39.9% | |
| Nov 14, 2024 | Marcus Gail Boxer | Director | Sell | 2,212 | $158.53 | $350,671.62 | -2.2% | +13.8% | +35.2% | |
| Nov 13, 2024 | Sheena Jonathan46 | Director, Co-founder | Sell | 36,300 | $154.86 | $5,621,396.41 | -4.2% | +5.4% | +24.7% |